Men lose their Y chromosome as they age-and it could be silently triggering heart attacks. Researchers tracking over 5,000 ...
Despite 700% net product revenue growth to $113 million, ImmunityBio's high debt load and unprofitability remain significant ...
Elon Musk has a new target in his sights, and it is not Mars or a self-driving car. In recent comments, he has argued that ...
Nivolumab plus AVD significantly improves PFS compared to brentuximab vedotin plus AVD in advanced-stage classic Hodgkin lymphoma, with a 91% vs 82% 3-year PFS rate. The PFS benefit of nivolumab plus ...
Scientists can peer into cells to get a limited view of their activity using microscopes and other tools. However, cells and ...
Stricter traffic enforcement and point rules in NYC and New York State are increasing fines, suspensions, and job risks ...
Metabolic dysfunction-associated steatotic liver disease (MASLD), previously referred to as NAFLD, represents the most prevalent liver disorder globally, ...
Gradalis announces positive results from phase 2b VITAL trial of Vigil to treat patients with newly diagnosed Stage IIIb–IV epithelial ovarian cancer: Dallas Friday, January 16, ...